Applied DNA Sciences (NASDAQ:APDN – Get Free Report) is anticipated to announce its earnings results before the market opens on Thursday, February 13th. Analysts expect the company to announce earnings of ($0.32) per share and revenue of $1.18 million for the quarter.
Applied DNA Sciences (NASDAQ:APDN – Get Free Report) last posted its quarterly earnings results on Tuesday, December 17th. The technology company reported ($0.32) earnings per share for the quarter, topping the consensus estimate of ($0.33) by $0.01. Applied DNA Sciences had a negative return on equity of 111.18% and a negative net margin of 203.76%.
Applied DNA Sciences Trading Up 0.7 %
NASDAQ APDN opened at $0.17 on Thursday. Applied DNA Sciences has a 12 month low of $0.12 and a 12 month high of $14.40. The stock has a 50 day moving average of $0.19 and a 200-day moving average of $0.53. The company has a market cap of $9.45 million, a PE ratio of -0.02 and a beta of 0.37.
Applied DNA Sciences Company Profile
Applied DNA Sciences, Inc, a biotechnology company, develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) in the Americas, Europe, Asia, and internationally. It operates through three segments: Therapeutic DNA Production Services; MDx Testing Services; and DNA Tagging and Security Products and Services.
Read More
- Five stocks we like better than Applied DNA Sciences
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- 3 Must-Have ETFs Set to Dominate This Quarter
- Election Stocks: How Elections Affect the Stock Market
- Seeking Stability? These 3 Stocks Offer Strong Potential
- Upcoming IPO Stock Lockup Period, Explained
- Trade War Bargain Stocks: Top 3 Picks Too Good to Pass Up
Receive News & Ratings for Applied DNA Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Applied DNA Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
